Effectiveness of a Technology-Based Collaborative Care Model to Manage Postpartum Hypertension and Improve Preventive Care Attendance in Rhode Island
Led by Women and Infants Hospital of Rhode Island · Updated on 2025-06-17
1536
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate a technology-based collaborative care model called RI-SPHERES among postpartum patients with hypertensive disorders of pregnancy HDP. The trial will test whether RI-SPHERES is not worse than a standard self-measured blood pressure SMBP program in controlling persistent hypertension six weeks after delivery and improving preventive care attendance within one year. The study addresses challenges like low adherence to blood pressure checks due to barriers such as childcare and transportation, especially in racial or ethnic minority groups.
Participants will be randomly assigned to one of two groups the RI-SPHERES group or the standard SMBP program group. The RI-SPHERES group will use a LTE-enabled blood pressure cuff syncing to a smartphone app that sends automated reminders and adaptive messages based on blood pressure readings and symptoms, with a nurse practitioner-led collaborative care team supporting patients. The first six weeks focus on blood pressure control, then shift to preventive care support for up to one year. The standard SMBP group will manually enter blood pressure readings into an electronic record to be reviewed by clinical staff, with recommendations for monthly blood pressure checks and preventive care after six weeks postpartum.
Participants will be involved for one year postpartum, during which blood pressure measurements, preventive care visits, and maternal health outcomes will be monitored. Assessments include short- and long-term blood pressure control, severe maternal morbidity, emergency visits, hospital readmissions, medication adjustments, and patient satisfaction. The study will also evaluate equity in care related to race, ethnicity, language, and geography. Data will be collected through the app, electronic medical records, and regular communications with the study team to track adherence and health outcomes.
CONDITIONS
Brief Title
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
Research Team
S
Stephanie Nunez, Research Coordinator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
RI‑SPHERES (investigational)
Standard self‑measured blood pressure program
What this option is
A behavioral remote surveillance program where a care manager guides postpartum hypertension management via an app, self‑measured blood pressure cuff syncing, adaptive messaging, education, and referrals
A standard self‑measured blood pressure (SMBP) program using MyChart to report readings, with basic education and follow‑up via portal messaging
Primary aim or use
To remotely monitor postpartum hypertension and support preventive care through care manager engagement
To monitor postpartum hypertension using home blood pressure monitoring and MyChart reporting under existing SMBP infrastructure
How it is delivered
Care manager provides virtual or in‑person introduction, app syncing of LTE blood pressure cuff, adaptive messaging, referrals, and monthly preventive care follow‑up
Participants are taught SMBP, report via MyChart, receive messaging, and at six weeks get a reminder message to obtain monthly blood pressure and visit a primary care provider
Evidence beyond this trial
Remote SMBP or telehealth monitoring postpartum has been associated with lower readmission rates and improved guideline adherence compared with standard care
Self‑measured blood pressure monitoring at home is commonly used and supported by professional consensus to improve postpartum blood pressure detection
Important limitations
Requires smartphone ownership, LTE‑enabled cuff, language support and care manager access which may limit accessibility
Depends on participant‑entered readings and remote messaging without care manager support or referrals
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 60Years
FEMALE
Eligibility Criteria
You may qualify if you...
Postpartum patient aged 18 years or more at any birthing hospital in Rhode Island
Diagnosed during pregnancy or after delivery with hypertensive disorder of pregnancy
Speaks English, Spanish, Portuguese, or Haitian-Creole
Owns a smartphone
You will not qualify if you...
Prior enrollment in this trial
Prisoners or incarcerated people
Unable or unwilling to provide informed consent
Unable to communicate with study team, even with an interpreter
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Treatment
Duration - Up to 1 year postpartum
Participants engage in a self-measured blood pressure program. Those in the RI-SPHERES group use a Bluetooth-enabled blood pressure cuff synced to an app with automated reminders and adaptive messaging for the first six weeks postpartum. After six weeks, the focus shifts to preventive care with monthly engagement from a care manager to ensure primary care and specialist visits. Participants in the standard program manually report blood pressure readings and receive guidance to attend preventive care visits after six weeks.
Weekly or monthly virtual or in-person contacts depending on study group, including initial introduction and ongoing support
Follow-up
Duration - From six weeks postpartum until one year postpartum
Participants continue to be monitored for persistent hypertension and attendance of preventive care visits up to one year postpartum.
Monthly check-ins and preventive care visits as recommended
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Randomized Trial of Dapagliflozin for Lowering Heart Risk After Hypertensive Pregnancy in the Postpartum Period
Long-Term Heart and Blood Vessel Study in Adults Born to Mothers with High Blood Pressure During Pregnancy
Treatment of American Heart AssociationAmerican College of Cardiology Stage 1 Hypertension in Pregnancy A Randomized Control Trial
Study of Breathing and Kegel Exercises to Improve Core Strength, Reduce Pain, and Decrease Abdominal Separation After Cesarean Delivery in Postpartum Women Aged 18 to 40
Study Comparing Forearm Conical and Upper Arm Cylindrical Blood Pressure Cuffs for Pregnant Women with Hypertension and Obesity
Comparing Scapular Posterior Tilt Exercises and Cross-Body Stretching to Improve Breastfeeding and Posture in Postpartum Women with Rounded Shoulders
Comparing Usual Postpartum Care With a Text and Phone Program to Reduce Emergency Visits After Delivery
IMPACT Study Comparing In-Person Education and Telehealth Models
for Postpartum Care in Underserved Urban Women
Study of Inorganic Nitrate Supplements to Control Blood Pressure in Pregnant Women with Chronic Hypertension Starting in the Second Trimester
Randomized Trial Comparing Labetalol and Nifedipine for Managing Postpartum Hypertension
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Protocol for a type 1 hybrid effectiveness implementation trial to evaluate whether a technology-based collaborative care model is non-inferior to remote blood pressure monitoring on persistent hypertension and preventive care attendance among postpartum people with hypertension.
Stephanie D Nuñez, Lindsay M Spratt, Crystal F Ware...